View in EDS HTML Full Text PDF Full Text

The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis.

Saved in:
Bibliographic Details
Title: The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis.
Authors: Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Porta FM; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Olmeda E; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Gaeta A; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Conversano F; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., De Pas TM; Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo 24125, Italy., Castellano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Santoro C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Battaiotto E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Mane E; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Coppola S; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan 20141, Italy., Conforti F; Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo 24125, Italy., Mattar D; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan 20141, Italy., Gandini S; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Veronesi P; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan 20141, Italy., Guerini Rocco E; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Pennacchioli E; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan 20141, Italy., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.
Source: The oncologist [Oncologist] 2025 Feb 06; Vol. 30 (2).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1549-490X
DOI:10.1093/oncolo/oyaf012